“…Although various studies have investigated the role of dystrophin in DMD, little is known about the therapeutic potential of targeting intermediate filaments, which have an important role in linking sarcomeres to the extracellular matrix. The characterization of desmin as a potential therapeutic target that could attenuate muscle wasting in a DMD model is an important implication reported by Ferry et al (2020) in The Journal of Physiology. In their study, Ferry et al (2020) provide experimental evidence indicating that desmin, a muscle-specific, type III intermediate filament, may play important roles in locomotor muscle performance, fragility and wasting in dystrophic mdx mice.…”